Sanofi US

Sanofi US FOR U.S. RESIDENTS ONLY. We are Sanofi, an innovative global healthcare company. This page is intended to provide a forum for discussions regarding Sanofi US.

Interactions with our Sanofi US page must comply with our terms: https://www.sanofi.us/en/legal-notice. If treatments are discussed, we can only allow messages that are in accordance with the FDA approved use. This page is not intended as a forum for reporting Sanofi US or other company's products' side effects associated with the use of prescription drugs. For more information on our products, please visit https://www.sanofi.us/en/products-and-resources. For questions relating to our products or treatments, please visit https://www.sanofi.us/en/contact-us. MAT-US-2200346-v5.0-08/2023

04/11/2025

Diagnosed with leukemia as a college freshman, one woman faced her toughest health challenges head-on including chronic Graft-versus-host-disease (cGVHD), a condition that can occur after a bone marrow or stem cell transplant.

She transformed her journey into a mission, becoming a nurse and dedicating 20 years to guiding others through similar health challenges. Today, she is a brave advocate sparking hope for those living with cGHVD.

Check out her full story here: http://spkl.io/6184AwRv0

29/10/2025

What’s your biggest dream? 🩺✨
Every day, we chase the miracles of science so you can chase your dreams. If you’ve ever thought about stopping, don’t! We’re right beside you.

Learn about why we’re chasing the miracles of science in the link in our bio.

22/10/2025

Uniting for impact at our annual Trust, Inclusion, & Equity (TIE) Summit.

When we listen and act together, we create a healthcare system that works for everyone.

Did you know that, although most cases are mild, respiratory syncytial virus (RSV) is a leading cause of hospitalization...
17/10/2025

Did you know that, although most cases are mild, respiratory syncytial virus (RSV) is a leading cause of hospitalization for babies under 1?

is a powerful reminder for parents, caregivers, and communities to learn how they can help protect babies from serious RSV lung infections.

To help raise awareness, Dr. Ayman Chit from sat down with a pediatrician to talk about:

👶 The real impact RSV has on families
🏥 Shifting RSV hospitalization rates over the past few years
💉 How prevention options are helping

💬 Whether you're a parent, grandparent, or healthcare provider, this is a conversation you won’t want to miss.

👉 Learn more and join the movement to help protect babies: http://spkl.io/6186AXMpn

16/10/2025

We gave one of our scientists a disposable camera to capture his day at work 📸🔬

From uncovering one of America’s first community-spread COVID-19 cases to leading a state-wide vaccination effort, Dr. K...
24/09/2025

From uncovering one of America’s first community-spread COVID-19 cases to leading a state-wide vaccination effort, Dr. Katie Sharff’s curiosity has helped drive breakthrough discoveries. Now at Sanofi, she is fostering that same curiosity to ask the bold questions that will help shape the future of vaccines.

Read her story: http://spkl.io/6180AT86m

As a scientist, Diego Perez Gamboa isn't just advancing innovative research—he's also transforming workplace culture as ...
18/09/2025

As a scientist, Diego Perez Gamboa isn't just advancing innovative research—he's also transforming workplace culture as Co-Lead for the Advancing Latin American Momentum and Achievement (ALMA) Employee Business Resource Group (EBRG).

Originally from Guadalajara, Mexico and now based in Cambridge, Massachusetts, he's working alongside ALMA members this Hispanic Heritage Month—and beyond—to turn opportunity into meaningful action.

18/09/2025

Meet the 2025 TORCH Award recipients!

These passionate advocates, changemakers and champions are making a lasting difference in the and communities.

Join us in celebrating their transformative efforts — driving innovation, raising awareness and inspiring change.

Watch their powerful stories here ➡️ http://spkl.io/6188AR7un

15/09/2025

Leukemia survivor Lew Christie knows firsthand the challenges of living with Graft-versus-host disease ( ), a complication that can occur after an allogeneic bone marrow or stem cell transplant, commonly used to treat blood cancers.

Join us in raising awareness and celebrating the strength and resilience of those living with GVHD.

Check out Lew’s inspiring story: http://bit.ly/45HmOLF

It’s time to . This , we’re joining forces with the International Myeloma Foundation to raise awareness of – a blood...
02/09/2025

It’s time to . This , we’re joining forces with the International Myeloma Foundation to raise awareness of – a blood cancer diagnosed in nearly 36,000 Americans each year.

Together, we hope to address misconceptions surrounding this complex disease and advance patient-centric research to improve outcomes for those impacted by this disease.

Learn more: http://spkl.io/6189AO0Zv

25/08/2025

Bold voices are making a difference in rare conditions and beyond. From rare diseases to rare blood disorders, the TORCH Awards continue to honor those driving meaningful change for patients and families.

On September 18, we’ll celebrate the 2025 recipients, including advocates, leaders, and changemakers who are lighting the way forward.

Want to learn more about the story behind the TORCH Awards? Explore the history here: http://spkl.io/6188A3upm

Address


Website

https://www.linkedin.com/company/sanofi/

Alerts

Be the first to know and let us send you an email when Sanofi US posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Sanofi US:

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Terms of Use The Sanofi US Facebook timeline is open to your comments. We welcome engaging in a dialogue with you, but please note that we operate in a regulated industry. In this highly regulated environment the Company has chosen to remove certain posts. This page is intended to provide a forum for discussions regarding Sanofi US. If treatments are discussed, we can only allow messages that are in accordance with the FDA approved use. This page is not intended as a forum for reporting Sanofi US or other company's products' side effects associated with the use of prescription drugs. If comments include possible adverse events or side effects associated with any product, Sanofi US may be required to contact you for further information, per the company's Adverse Events Reporting Guidelines. Sanofi US is not responsible for the postings and opinions of third parties. Sanofi US does not verify, approve or endorse the comments or any information posted by visitors to this page, does not warrant their accuracy, and assumes no responsibility or liability arising from content of the page nor for any error, omission, defamation, libel, or slander. Caution should be used before relying on any particular statements or opinions expressed herein. Please visit http://www.sanofi.us/l/us/en/layout.jsp?scat=8D4FB6C0-9DD0-4C74-8C94-9859D8B2687B for information on Sanofi US products. For product-related or other questions, please visit http://contactus.sanofi.us/default.aspx to contact the appropriate Sanofi US department. If you, or someone you know, have possibly experienced a side effect while taking any Sanofi US product, please contact our Drug Safety Department at 1-800-633-1610, option 2, or via fax at 1-908-203-7783. You are also encouraged to report side effects of prescription drugs to the FDA. To do so, visit www.fda.gov/medwatch or call 1-800-FDA-1088. We reserve the right to block users from this page who violate the Terms of Use. We reserve the right to remove this page and its contents at any time. Please check often for updates, as we reserve the right, in our sole discretion, to modify these Terms of Use at any time. Your use of this page indicates your acceptance of any revisions to these terms.